+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Electroencephelographs (EEG)-Pipeline Insight and Competitive Landscape, 2022

  • PDF Icon

    Drug Pipelines

  • 60 Pages
  • July 2022
  • Region: Global
  • DelveInsight
  • ID: 5525556
This “Electroencephelographs (EEG)-Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape. Increased incidence of disorders like Alzheimer's disease, epilepsy, Dementia, Multiple Sclerosis, Parkinson's disease, and stroke around the world has been crucial to elevate the use of electroencephalography (EEG) products. Growing prevalence of neurological diseases and increasing awareness about these are significant contributing factors to advancement. Hence, the market is expected to growth in the coming years. The industries invest in R&D to upgrade existing products and create new ones to satisfy the rising demand for specialized equipment, which is the major reason for an extensive pipeline in this segment. This report provides a detailed study of the emerging Electroencephelographs devices along with competitive landscape to help better understand the emerging Electroencephelographs devices.

Geography Covered

  • Global coverage
Electroencephelographs Overview

Electroencephelographs: Understanding

An electroencephalogram (EEG) is a noninvasive test that records electrical patterns in your brain. The test is used to help diagnose conditions such as seizures, epilepsy, head injuries, dizziness, headaches, brain tumors and sleeping problems. It can also be used to confirm brain death.

How does an EEG work?
The billions of nerve cells in your brain produce very small electrical signals that form patterns called brain waves. During an EEG, small electrodes and wires are attached to your head. The electrodes detect your brain waves and the EEG machine amplifies the signals and records them in a wave pattern on graph paper or a computer screen.

Electroencephelographs Devices Competitive Assessment

This segment of the Electroencephelographs report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates and the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
  • Product Type
Electroencephelographs can divided based on Types - Standalone devices and Portable devices- both are covered in this report.
  • Product Channels
Electroencephelographs can be divided based on Channels - 8-channel EEG, 21-channel EEG, 25 channel EEG, 32-channel EEG, 40-channel EEG, Multi-channel EEG.
  • Major Players in Electroencephelographs
There are approx. 20+ key companies which are developing the products for Electroencephelographs.
  • Cerora Borealis: Cerora
The Cerora Borealis medical device platform is subject to FDA review and designed to measure and record brainwave activity (EEG) as well as other biosensor data, including cognitive data and voice-based data streams. The platform provides state of the art, mobile and versatile multimodal biosensor data. The first release is intended as an adjunct to standard clinical practice to aid in the evaluation of subject's medical or psychological state. Cerora's next generation devices are intended to aid in the diagnosis and management of various brain disorders, injuries, and diseases. The first release of Borealis is estimated to ship into US markets in 2021 at the earliest.
  • Circaid EEG: Circadian Therapeutics
Circaid EEG is being developed by Circadian Therapeutics. Its proof of concept study has already being done and prototype dev phase is ongoing. In a controlled clinical evaluation, data obtained using Circaid EEG® correlate highly with those derived from traditional PSG recording equipment. Work continues towards CE marking and US 510(k) approval.

Further product details are provided in the report……..

Electroencephelographs (EEG) Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.

The analysis is based on
  • Brand Positioning of Leading companies
  • Application
  • Industry Collaborations
Electroencephelographs (EEG): Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of EEG devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.

Development Activities
  • In June 2020 a study investigating EEG microstate dynamics in schizophrenia was the first research on the temporal structure of the four canonical EEG microstates of schizophrenic patient siblings. Results indicate that a possible endophenotype for schizophrenia is the dynamics of resting-state EEG microstats, specifically classes C and D.
  • In April 2020, Marking a major milestone on the path to meeting the objectives of the NIH BRAIN initiative, researchers developed advanced high-density electroencephalography (EEG) as the future paradigm for dynamic functional neuroimaging. The study also marks one of the first times high-density EEG has been used to study epileptic seizures. The more powerful imaging technology, packing more than double the electrodes generally used in a clinical setting, is now available to patients treated at the Mayo Clinic.
Further commercial activities are provided in the report……..

Electroencephelographs (EEG): Reimbursement
  • US
FDA approval alone is not a basis for coverage. Electroencephalographic (EEG) monitoring and video recording is a procedure and therefore is not regulated by the FDA. Medicare does not have a National Coverage Determination (NCD) for electroencephalographic (EEG) monitoring and video recording. Local Coverage Determinations (LCDs) exist.

Further information is provided in the report……..

Report Highlights

  • Extensive coverage of the Electroencephelographs under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electroencephelographs and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
  • The report consists of in depth analysis of pipeline products based on various parameters
Electroencephelographs Report Insights
  • Electroencephelographs - Pipeline Analysis
  • Electroencephelographs - Unmet Need
  • Electroencephelographs - Market Dynamics
  • Electroencephelographs - Future Perspectives and Conclusion
  • Electroencephelographs - Analyst Views

Key Questions

  • What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
  • How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
  • What are important and diverse types of Electroencephelographs under development?
  • What are market-entry and market expansion strategies in Electroencephelographs?
  • What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
  • What is in-depth analysis of the product's current stage of development, territory and estimated launch date?
Key Players
  • AAT Medical Ltd
  • Advanced Medical Electronics Corp
  • Advanced neurometrics inc.
  • Belluscura Limited
  • BioSignal Analytics Inc
  • Bio-Signal Group Corp.
  • Bittium Biosignals Ltd
  • BrainCare OY'
  • BrainScope Company Inc
  • Cerora Inc
  • Circadian Therapeutics
  • Cognionics, Inc.
  • Cogwear LLC
  • Compumedics Ltd
  • Electrical Geodesics Inc

Table of Contents

1. Key Insights

2. Electroencephelographs: Snapshot

3. Electroencephelographs
3.1. Product Overview
3.2. Regulatory Approvals based on Class
3.3. Indications
3.4. Mechanism

4. Electroencephelographs: Competitive Assessment
4.1. Assessment by Product Channels
4.2. Assessment by Product Type
4.3. Assessment by Application
4.3.1. Parkinson's disease
4.3.2. Epilepsy
4.3.3. Alzheimer's Disease
4.3.4. Dementia
4.3.5. Multiple Sclerosis
4.4. Assessment by Company
4.4.1. Cerora Cerora Borealis: Cerora Product Information Research and Development Patent Details Regulatory Milestone
4.4.2. Circadian Therapeutics Circaid EEG: Circadian Therapeutics Product Information Research and Development Patent Details Regulatory Milestone
*More Companies and products would be added in the final report

5. Electroencephelographs: Competitive Benchmarking: By Company
5.1. Brand Positioning of Leading companies
5.2. Analysis based on Application
5.3. Analysis based on Industry Collaborations

6. Electroencephelographs - Commercialization Activity
6.1. Collaboration
6.2. Licensing
6.3. Merger and Acquisition
6.4. Recent Breakthroughs
6.5. Literature Studies
6.6. KOL Views

7. Electroencephelographs: Regulatory
7.1. US
7.2. Europe
7.3. Japan

8. Electroencephelographs: Reimbursement
8.1. Case Study - US
8.2. Case Study - Europe
8.3. Case Study -Japan

9. Electroencephelographs: Market Dynamics
9.1. Unmet Needs
9.2. Market Drivers
9.3. Market Barriers

10. Analytical Perspective
10.1. PEST Analysis
10.2. Future Growth Perspectives

11. Conclusion

12. Appendix
12.1. Research Methodology
12.1.1. Coverage
12.1.2. Secondary Research

13. Bibliography

14. Publisher Capabilities

15. Disclaimer

16. About the PublisherList of Tables
Table 1 Total Pipeline Products
Table 3 Pipeline Products by Technology
Table 4 Pipeline Products by Type
Table 6 List of Companies
Table 7 Cerora Pipeline Products & Ongoing Clinical Trials Overview
Table 8 Cerora Borealis - Product Status
Table 9 Cerora Borealis - Product Description
Table 10 Circadian Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 11 Circaid EEG - Product Status
Table 12 Circaid EEG - Product DescriptionList of Figures
Figure 1 List of Pipeline Products
Figure 2 Ongoing Clinical Trial
Figure 3 Ongoing Clinical Trial Pipeline Products by Technology
Figure 4 Ongoing Clinical Trial Pipeline Products by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AAT Medical Ltd
  • Advanced Medical Electronics Corp
  • Advanced neurometrics inc.
  • Belluscura Limited
  • BioSignal Analytics Inc
  • Bio-Signal Group Corp.
  • Bittium Biosignals Ltd
  • BrainCare OY’
  • BrainScope Company Inc
  • Cerora Inc
  • Circadian Therapeutics
  • Cognionics, Inc.
  • Cogwear LLC
  • Compumedics Ltd
  • Electrical Geodesics Inc